مباشر
FierceBiotechCeQur nabs $100M series E to fuel insulin patch commercialization10x Genomics News10x Genomics acquires Proteintech Genomics division - Investing.comPharmaVoiceWith a promising MASH asset, muscle-sparing GLP-1 and new CEO, Rivus gets ready to make its markPharmaVoiceWill obesity drugs save Pfizer from its post-COVID slump?10x Genomics News10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group - TradingViewPromega BlogThe Molecular Blueprint for Virus-Resistant CowpeaFierceBiotechWith ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity raceFierceBiotechThe new standard for trusted AI in biopharmaEndpoints NewsPost-Hoc Live: How much is everyone in biopharma getting paid?BioWorldAppointments and advancements for June 9, 2026BioWorldFinancings for June 9, 2026BioWorldIn the clinic for June 9, 2026
BioWorld ٥ ديسمبر ٢٠٢٥

Synnovation Therapeutics discovers new NRF2 inhibitors

Synnovation Therapeutics discovers new NRF2 inhibitors

المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.